About KriyaBio
KriyaBio is a company based in Geneve (Switzerland) founded in 2020 by Christiane Borchard and Hanns Christian Mahler. The company has 1 employees as of July 01, 2024. KriyaBio offers products and services including KB01 and Drug Delivery Solutions. KriyaBio operates in a competitive market with competitors including EyePoint Pharmaceuticals, Rezolute, PanTher Therapeutics, PolyPid and Molecular Partners, among others.
- Headquarter Geneve, Switzerland
- Employees 1 as on 01 Jul, 2024
- Founders Christiane Borchard, Hanns Christian Mahler
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kriyabio Sa
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1
as on Jul 01, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of KriyaBio
KriyaBio offers a comprehensive portfolio of products and services, including KB01 and Drug Delivery Solutions.
Proprietary technology for paracellular drug transport in pharmaceuticals
Services to advance early-stage portfolios and extend product lifecycles
Funding Insights of KriyaBio
Detailed funding history for KriyaBio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by KriyaBio
Investment portfolio details for KriyaBio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - KriyaBio
Detailed financials for KriyaBio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kriyabio Comparisons
Peer comparison for KriyaBio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of KriyaBio
KriyaBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EyePoint Pharmaceuticals, Rezolute, PanTher Therapeutics, PolyPid and Molecular Partners, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Small molecule therapeutics for ophthalmic disorders are developed.
|
|
| Locked | Locked | Locked |
Therapies for metabolic and orphan diseases are developed by Rezolute.
|
|
| Locked | Locked | Locked |
Drug delivery systems for inoperable solid tumors are developed.
|
|
| Locked | Locked | Locked |
Technology platform enabling controlled and prolonged release of any Active Pharmaceutical Ingredient (API)
|
|
| Locked | Locked | Locked |
Therapeutic solutions for diseases are developed using DARPin technology.
|
|
| Locked | Locked | Locked |
Biotherapeutics for glycol-immune diseases are developed across multiple therapeutic areas.
|
Detailed competitors of KriyaBio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kriyabio
Complete news archive for KriyaBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about KriyaBio
KriyaBio was founded in 2020.
KriyaBio is headquartered in Geneve, Switzerland. It is registered at Geneve, Geneve, Switzerland.
As of Jul 01, 2024, the latest employee count at KriyaBio is 1.
KriyaBio was founded in 2020 and is based in Geneva, Switzerland. Topical drug delivery technologies for ophthalmology are developed by the company, with a focus on the KB01 permeation enhancer. This modulator enables enhanced absorption of co-administered therapies, particularly for age-related macular degeneration (AMD) treatments. Operations center on advancing smart tight junction modulation in the biotech sector for ocular conditions.
KriyaBio's top competitors include PanTher Therapeutics, EyePoint Pharmaceuticals and Rezolute.
KriyaBio offers KB01 and Drug Delivery Solutions.